1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN
Momentum Trap
Download real time
124.97 -3.76 (-2.92%)
28.90% Fall from 52W High
861.0K
XNAS Volume

XNAS 02 Mar, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Repligen Corp is on 13 Mar 2026 for the purpose of Repligen Corp Annual Report for 2025 See details

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts

Repligen Corp has a share price target of US$ 186, revenue growth forecast of 11.9%, and profit growth estimate of 22.4% for FY26, based on top 21 analyst calls.

Forecaster Screeners